Human papillomaviruses and associated malignancies

Journal of Clinical Oncology

Volumn 16, Issue 1, 1998, Pages 330-337

  Alani, Rhoda M ^a   Münger, Karl ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANUS CARCINOMA; ARTICLE; CANCER RISK; CELL PROLIFERATION; CONDYLOMA ACUMINATUM; DNA VIRUS; GENITAL TRACT CANCER; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; VIRUS CARCINOGENESIS; VIRUS ONCOGENE; WART VIRUS;

EID: 0344269308     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.1.330     Document Type: Article

References (52)

1. DeVilliers EM: Heterogeneity of the human papillomavirus group. J Virol 63:4898-4903, 1989
2. zur Hausen H: Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184:9-13, 1991
3. Evander M, Frazer IH, Payne E, et al: Identification of the alpha 6 integrin as a candidate receptor for papillomaviruses. J Virol 71:2449-2456, 1997
4. Howley PM: Papillomavirinae: The viruses and their replication, in Fields BN, Knipe DM, Howley PM (eds): Fundamental Virology. Philadelphia, PA, Lippincott-Raven, 1996, pp 947-978
5. Sherr CJ: Cancer cell cycles. Science 274:1672-1677, 1996
6. Nasmyth K: Viewpoint: Putting the cell cycle in order. Science 274:1643-1645, 1996
7. King RW, Deshaies RJ, Peters J-M. et al: How proteolysis drives the cell cycle. Science 274:1652-1659, 1996
8. Elledge SJ: Cell cycle checkpoints: Preventing an identity crisis. Science 274:1664-1672, 1996
9. Schneider-Gädicke A, Schwarz E: Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes. EMBO J 5:2285-2292, 1986
10. zur Hausen H: Viruses in human cancer. Science 254:1167-1172, 1991
11. Woodworth CD, Waggoner S, Barnes W, et al: Human cervical and foreskin epithelial cells immortalized by human papillomavirus DNAs exhibit dysplastic differentiation in vivo. Cancer Res 50:3709-3715, 1990
12. Hawley-Nelson P, Vousden KH, Hubbert NL, et al: HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J 8:3905-3910, 1989
13. Münger K, Phelps WC, Bubb V, et al: The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 63:4417-4421, 1989
14. McCance DJ, Kopan R, Fuchs E, et al: Human papillomavirus type 16 alters human epithelial cell differentiation in vitro. Proc Natl Acad Sci USA 85:7169-7173, 1988
15. Pecoraro G, Morgan D, Defendi V: Differential effects of human papillomavirus type 6, 16, and 18 DNAs on immortalization and transformation of human cervical epithelial cells. Proc Natl Acad Sci USA 86:563-567, 1989
16. Hudson JB, Bedell MA, McCance DJ, et al: Immortalization and altered differentiation of human keratinocytes in vitro by the E6 and E7 open reading frames of human papillomavirus type 18. J Virol 64:519-526, 1990
17. Blanton RA, Coltrera MD, Gown AM, et al: Expression of the HPV16 E7 gene generates proliferation in stratified squamous cell cultures which is independent of endogenous p53 levels. Cell Growth Differ 3:791-802, 1992
18. Woodworth CD, Cheng S, Simpson S, et al: Recombinant retroviruses encoding human papillomavirus type 18 E6 and E7 genes stimulate proliferation and delay differentiation of human keratinocytes early after infection. Oncogene 7:619-626, 1992
19. Levine AJ: p53, cellular gatekeeper for growth and division. Cell 88:323-331, 1997
20. Vogelstein B, Kinzler KW: p53 function and dysfunction. Cell 70:523-526. 1992
21. zur Hausen H: Papillomavirus infections - A major cause of human cancers. Biochem Biophys Acta 1288:F55-F78, 1996
22. Chen JJ, Reid CE, Band V, et al: Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein. Science 269:529-531, 1995
23. Tong X, Howley PM: The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton. Proc Natl Acad Sci USA 94:4412-4417, 1997
24. Phelps WC, Yee CL, Münger K, et al: The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to adenovirus E1a. Cell 53:539-547, 1988
25. Figge J, Webster T, Smith TF, et al: Prediction of similar transforming regions in simian virus 40 large T, adenovirus E1A and myc oncoproteins. J Virol 62:1814-1818, 1988
26. Barbosa MS, Lowy DR, Schiller JT: Papillomavirus polypeptides E6 and E7 are zinc-binding proteins. J Virol 63:1404-1407, 1989
27. Whyte P, Williamson NM, Harlow E: Cellular targets for transformation by the adenovirus E1A proteins. Cell 56:67-75, 1989
28. DeCaprio JA, Ludlow JW, Figge J, et al: SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54:275-283, 1988
29. Ewen ME, Ludlow JW, Marsilio E, et al: An N-terminal transformation governing sequence of SV40 large T antigen contributes to the binding of both p110Rb and a second cellular protein. p120. Cell 58:257-267, 1989
30. Münger K, Werness BA, Dyson N, et al: Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J 8:4099-4105, 1989
31. Dyson N, Guida P, McCall C, et al: Adenovirus E1A makes two distinct contacts with the retinoblastoma protein. J Virol 66:4606-4611, 1992
32. Jones DL, Münger K: Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein. J Virol 71:2905-2912, 1997
33. Zerfass-Thome K, Zwerschke W, Mannhardt B, et al: Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein. Oncogene 13:2323-2330, 1996
34. Jones DL, Alani RM, Münger K: The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2. Genes Dev 11:2101-2111, 1997
35. Funk JO, Waga S, Harry JB, et al: Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. Genes Dev 11:2090-2100, 1997
36. Hinds PW, Mittnacht S, Dulic V, et al: Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70:993-1006, 1992
37. Ewen ME, Sluss HK, Sherr CJ, et al: Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73:487-497, 1993
38. Kato J, Matsushime H, Hiebert SW, et al: Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev 7:331-342, 1993
39. Demers GW, Foster SA, Halbert CL, et al: Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7. Proc Natl Acad Sci USA 91:4382-4386, 1994
40. Slebos RJC, Lee MH, Plunkett BS, et al: p53-dependent G(1) arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc Natl Acad Sci USA 91:5320-5324, 1994
41. Gissmann L: Immunologic responses to human papillomavirus infection. Obstet Gynecol Clin North Am 23:625-639, 1996
42. Wright TC, Sun XW: Anogenital papillomavirus infection and neoplasia in immunodeficient women. Obstet Gynecol Clin North Am 23:861-893, 1996
43. Franco ELF: Epidemiology of anogenital warts and cancer. Obstet Gynecol Clin North Am 23:597-623, 1996
44. Palefsky JM, Silverman S, Abdel-Salaam M, et al: Association between proliferative verrucous leukoplakia and infection with human papillomavirus type 16. J Oral Pathol Med 24:193-197, 1995
45. Majewski S, Jablonska S: Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin. Arch Dermatol 131:1312-1318, 1995
46. El-Zein R, Shaw P, Tying SK, et al: Chromosomal radiosensitivity of lymphocytes from skin cancer prone patients. Mutat Res 335:143-149, 1995
47. Barr BB, Benton EC, McLaren K, et al: Human papillomavirus infection and skin cancer in renal allograft recipients. Lancet 2:124-129, 1989
48. Shamanin V, zur Hausen H, Lavergne D, et al: Human papilloma-virus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst 88:802-811, 1996
49. Steele C, Cowsert LM, Shillitoe EJ: Effects of human papilloma-virus type-18-specific antisense oligonucleotides on the transformed phenotype of human carcinoma cell lines. Cancer Res 53:2330-2337, 1993
50. Dowhanick JJ, McBride AA, Howley PM: Suppression of cellular proliferation by the papillomavirus E2 protein. J Virol 69:7791-7799, 1995
51. Vernon SD, Unger ER, Miller DL, et al: Association of human papillomavirus type 16 integration in the E2 gene with poor disease-free survival from cervical cancer. Int J Cancer 74:50-56, 1997
52. Frazer IH: The role of vaccines in the control of STDs: HPV vaccines. Genitourin Med 72:398-403, 1996